Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Comparison of radiomics tools for image analyses and clinical prediction in nasopharynx cancer.

Liang ZG, Tan HQ, Zhang F, Rui Tan LK, Lin L, Lenkowicz J, Wang H, Wen Ong EH, Kusumawidjaja G, Phua JH, Gan SA, Sin SY, Ng YY, Kiat Tan TW, Soong YL, Fong KW, Park SY, Soo KC, Seng Wee JT, Zhu XD, Valentini V, Boldrini L, Sun Y, Kiang Chua ML.

Br J Radiol. 2019 Aug 27:20190271. doi: 10.1259/bjr.20190271. [Epub ahead of print]

PMID:
31453720
2.

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.

Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT.

Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33428-5. doi: 10.1016/j.ijrobp.2019.06.2540. [Epub ahead of print]

PMID:
31276776
3.

Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.

Sommat K, Hussain A, Ong WS, Yit NLF, Khoo JBK, Soong YL, Wee JTS, Fong KW, Tan TWK.

Radiother Oncol. 2019 Sep;138:149-157. doi: 10.1016/j.radonc.2019.05.023. Epub 2019 Jun 29.

PMID:
31265972
4.

Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.

Chua KLM, Yeo ELL, Shihabudeen WA, Tan SH, Shwe TT, Ong EHW, Lam PYP, Soo KC, Soong YL, Fong KW, Tan TWK, Wee JTS, Chua MLK.

BMC Cancer. 2018 Nov 12;18(1):1095. doi: 10.1186/s12885-018-5005-2.

5.

Anticariogenic efficacy of a saliva biomimetic in head-and-neck cancer patients undergoing radiotherapy.

Sim C, Walker GD, Manton DJ, Soong YL, Wee J, Adams GG, Reynolds EC.

Aust Dent J. 2019 Mar;64(1):47-54. doi: 10.1111/adj.12658. Epub 2018 Nov 11.

PMID:
30341773
6.

Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.

Sim C, Soong YL, Pang E, Lim C, Walker GD, Manton DJ, Reynolds EC, Wee J.

Aust Dent J. 2018 Jun;63(2):217-223. doi: 10.1111/adj.12608. Epub 2018 Apr 24.

PMID:
29569726
7.

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials.

Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, Ong WS, Tan T, Wee J, Li WF, Chen L, Ma BBY, Tong M, Tan SH, Cheah SL, Fong KW, Sommat K, Soong YL, Guo Y, Lin AH, Sun Y, Hong MH, Cao SM, Chen MY, Ma J.

Clin Cancer Res. 2018 Apr 15;24(8):1824-1833. doi: 10.1158/1078-0432.CCR-17-2656. Epub 2018 Feb 5.

8.

Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy.

Li YQ, Tian YM, Tan SH, Liu MZ, Kusumawidjaja G, Ong EHW, Zhao C, Tan TWK, Fong KW, Sommat K, Soong YL, Wee JTS, Han F, Chua MLK.

J Clin Oncol. 2018 Mar 20;36(9):891-899. doi: 10.1200/JCO.2017.75.5165. Epub 2018 Feb 7.

PMID:
29412781
9.

Practitioners' perspectives on community-based breast cancer survivorship care in Singapore: A focus group study.

Chan A, Ngai GH, Chung WL, Yeo A, Ng T, Loh KW, Farid M, Soong YL, Fok R.

Health Soc Care Community. 2018 May;26(3):404-411. doi: 10.1111/hsc.12528. Epub 2017 Dec 15.

PMID:
29243355
10.

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao Y, Yom SS, Wee JT.

Radiother Oncol. 2018 Jan;126(1):25-36. doi: 10.1016/j.radonc.2017.10.032. Epub 2017 Nov 15.

PMID:
29153464
11.

Dental extractions for preradiation dental clearance and incidence of osteoradionecrosis in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

See Toh YL, Soong YL, Chim YX, Tan LT, Lye WK, Teoh KH.

J Investig Clin Dent. 2018 May;9(2):e12295. doi: 10.1111/jicd.12295. Epub 2017 Sep 1.

PMID:
28862391
12.

Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.

Sommat K, Ong WS, Hussain A, Soong YL, Tan T, Wee J, Fong KW.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):574-580. doi: 10.1016/j.ijrobp.2017.03.007. Epub 2017 Mar 14.

PMID:
28581397
13.

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.

Vo JH, Nei WL, Hu M, Phyo WM, Wang F, Fong KW, Tan T, Soong YL, Cheah SL, Sommat K, Low H, Ling B, Ng J, Tan WL, Chan KS, Oon L, Ying JY, Tan MH.

Sci Rep. 2016 Dec 19;6(1):13. doi: 10.1038/s41598-016-0006-3.

14.

A 13-Year Single Institutional Experience with Definitive Radiotherapy in Hypopharyngeal Cancer.

Sommat K, Yong SK, Fong KW, Tan TW, Wee JT, Soong YL.

Ann Acad Med Singapore. 2017 Jan;46(1):32-36. No abstract available.

15.

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.

Rotolo F, Pignon JP, Bourhis J, Marguet S, Leclercq J, Tong Ng W, Ma J, Chan AT, Huang PY, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Soong YL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lee AW, Blanchard P, Michiels S; MAC-NPC Collaborative Group.

J Natl Cancer Inst. 2017 Apr;109(4). pii: djw239.

16.

Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.

Chua ML, Tan SH, Kusumawidjaja G, Shwe MT, Cheah SL, Fong KW, Soong YL, Wee JT, Tan TW.

Eur J Cancer. 2016 Nov;67:119-129. doi: 10.1016/j.ejca.2016.08.006. Epub 2016 Sep 16.

PMID:
27640138
17.

Nasopharyngeal carcinoma-some closing remarks.

Wee JT, Soong YL, Poh SS, Chua ML.

Chin Clin Oncol. 2016 Apr;5(2):29. doi: 10.21037/cco.2016.03.23. No abstract available.

18.

Nasopharyngeal carcinoma-past lessons and a glimpse into the future.

Wee JT, Soong YL, Chua ML.

Chin Clin Oncol. 2016 Apr;5(2):14. doi: 10.21037/cco.2016.04.03. No abstract available.

19.

Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.

Tan T, Lim WT, Fong KW, Cheah SL, Soong YL, Ang MK, Ng QS, Tan D, Ong WS, Tan SH, Yip C, Quah D, Soo KC, Wee J.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):952-60. doi: 10.1016/j.ijrobp.2015.01.002.

PMID:
25832687
20.

An assessment of the magnitude of intra-fraction movement of head-and-neck IMRT cases and its implication on the action-level of the imaging protocol.

Pang PP, Hendry J, Cheah SL, Soong YL, Fong KW, Wee TS, Tan WK, Nei WL, Wang F, Wong RX, Ng WL, Chen J.

Radiother Oncol. 2014 Sep;112(3):437-41. doi: 10.1016/j.radonc.2014.09.008. Epub 2014 Oct 2.

PMID:
25284062
21.

Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients.

Sim CP, Wee J, Xu Y, Cheung YB, Soong YL, Manton DJ.

Clin Oral Investig. 2015 Jun;19(5):1005-11. doi: 10.1007/s00784-014-1318-y. Epub 2014 Sep 27.

PMID:
25261399
22.

Electrospun PVP-indomethacin constituents for transdermal dressings and drug delivery devices.

Rasekh M, Karavasili C, Soong YL, Bouropoulos N, Morris M, Armitage D, Li X, Fatouros DG, Ahmad Z.

Int J Pharm. 2014 Oct 1;473(1-2):95-104. doi: 10.1016/j.ijpharm.2014.06.059. Epub 2014 Jul 2.

PMID:
24997411
23.

Serglycin expression: An independent marker of distant metastases in nasopharyngeal carcinoma.

Chia CS, Ong WS, Li XJ, Soong YL, Chong FT, Tan HK, Soo KC, Qian CN, Teh BT, Iyer NG.

Head Neck. 2016 Jan;38(1):21-8. doi: 10.1002/hed.23841. Epub 2015 Jan 27.

PMID:
24995621
24.

Intraoperative electron beam radiotherapy for primary treatment of stage IIB cervical cancer: a retrospective study.

Liu Z, Gao Y, Soong YL, Chen X, Gao F, Luo W, Sheng W, Ren J, Zhang L, Wang J.

J Int Med Res. 2012;40(6):2346-54.

PMID:
23321192
25.

Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.

Yeo RM, Chia YN, Namuduri RP, Yap SP, Soong YL, Yam PK, Lim TY, Khoo-Tan HS.

Gynecol Oncol. 2011 Nov;123(2):225-9. doi: 10.1016/j.ygyno.2011.06.040. Epub 2011 Jul 23.

PMID:
21782226
27.

Stage 1C grade 3 endometrial cancer: the KK Hospital gynaecological oncology group experience.

Siow TR, Yeo MC, Khoo-Tan HS, Yap SP, Soong YL, Chua EJ, Soh LT, Lim YK, Chia YN, Yam KL.

Int J Gynecol Cancer. 2010 Dec;20(9):1557-62. doi: 10.1111/IGC.0b013e3181fc4ff2.

PMID:
21119369
28.

The effect of prior radiation therapy for treatment of nasopharyngeal cancer on wound healing following extractions: incidence of complications and risk factors.

Lye KW, Wee J, Gao F, Neo PS, Soong YL, Poon CY.

Int J Oral Maxillofac Surg. 2007 Apr;36(4):315-20. Epub 2007 Jan 10.

PMID:
17222536
29.

Hepatitis B reactivation in a patient receiving radiolabeled rituximab.

Soong YL, Lee KM, Lui HF, Chow WC, Tao M, Li Er Loong S.

Ann Hematol. 2005 Jan;84(1):61-2. Epub 2004 Sep 23. No abstract available.

PMID:
15449029
30.

Primary nasal lymphoma, NK/T-cell type: report of two cases with similar presentation but different outcome.

Loong S, Soong YL, Tham I, Lee KM.

Australas Radiol. 2004 Mar;48(1):84-7.

PMID:
15027930
31.

The impact of some major specific causes of deaths on life expectancy in Taiwan (a comparison of 1952 and 1965).

Soong YL, Chow LP, Hsu TC.

Taiwan Yi Xue Hui Za Zhi. 1968 Jun 28;67(6):238-9. No abstract available.

PMID:
5254497

Supplemental Content

Loading ...
Support Center